Cidara Therapeutics, Inc. lost $26.75 per diluted share in fiscal year 2024. This represents a decrease of 409.5% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Cidara Therapeutics, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Cidara Therapeutics, Inc.'s diluted earnings per share in fiscal year 2024?
Cidara Therapeutics, Inc. lost $26.75 per diluted share in fiscal year 2024.
How fast is Cidara Therapeutics, Inc.'s diluted earnings per share growing?
Cidara Therapeutics, Inc. (CDTX) diluted earnings per share fell by 409.5% year over year, from -$5.25 to -$26.75 in fiscal year 2024.
What was Cidara Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?
Cidara Therapeutics, Inc. (CDTX) reported -$3.10 in diluted earnings per share in Q3 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Cidara Therapeutics, Inc. (CDTX) reported on that line in every period on record.
